Karen Hübscher
Director/Board Member bij TECAN GROUP AG
Vermogen: 360 229 $ op 31-03-2024
Profiel
Karen J.
Hübscher is the founder of FibulaMedical AG, which was founded in 2012.
She is currently Vice Chairman at Sandoz AG, Sandoz Group AG, and a Non-Executive Director at Tecan Group AG.
She also serves as a Director at IMD Scholarship Foundation, Schweizerische Management Gesellschaft, BBI Group Pty Ltd., and Dispopharm D&P AG.
Her former positions include Chief Executive Officer & Director at Solvias AG, Director-Investor Relations at Novartis AG from 2000 to 2006, and Member-European Commercial Operations at Novartis Vaccines & Diagnostics Services AG from 2006 to 2011.
Dr. Hübscher holds a graduate and doctorate degree from the Swiss Federal Institute of Technology and an MBA from the International Institute for Management Development.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
TECAN GROUP AG
0.01% | 31-12-2022 | 868 ( 0.01% ) | 360 229 $ | 31-03-2024 |
Actieve functies van Karen Hübscher
| Bedrijven | Functie | Begin |
|---|---|---|
| TECAN GROUP AG | Director/Board Member | 01-04-2012 |
| RUTILA RESOURCES LTD | Director/Board Member | - |
| SANDOZ GROUP AG | Director/Board Member | 01-08-2023 |
| Dispopharm D&P AG | Director/Board Member | - |
| FibulaMedical AG | Chief Executive Officer | 01-01-2012 |
| Schweizerische Management Gesellschaft | Director/Board Member | - |
| IMD Scholarship Foundation | Director/Board Member | - |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Director/Board Member | - |
Eerdere bekende functies van Karen Hübscher
| Bedrijven | Functie | Einde |
|---|---|---|
| Novartis Vaccines & Diagnostics Services AG | Corporate Officer/Principal | 01-01-2011 |
| ░░░░░░░░ ░░ | ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Opleiding van Karen Hübscher
| Swiss Federal Institute of Technology | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| TECAN GROUP AG | Health Technology |
| SANDOZ GROUP AG | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Health Technology |
Solvias AG
 Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Health Technology |
| IMD Scholarship Foundation | |
| Schweizerische Management Gesellschaft | |
BBI Group Pty Ltd.
 BBI Group Pty Ltd. Other Metals/MineralsNon-Energy Minerals BBI Group Ltd. operates as a resource and energy exploration company. Its projects include include Balla Balla and Eucla West Mineral Sands. The company was founded on October 8, 2009 and is headquartered in Sydney, Australia. | Non-Energy Minerals |
| Dispopharm D&P AG | |
| FibulaMedical AG | |
| Novartis Vaccines & Diagnostics Services AG |
